PRESS RELEASE: Microtechnix and Biomedica sign distribution agreement

Microtechnix, developer of the EMMA solution for automated microbial plate reading in environmental monitoring, is pleased to announce a strategic distribution and service partnership with Biomedica Medizinprodukte GmbH, a leading life sciences and diagnostics supplier based in Vienna, Austria.

Under this agreement, Biomedica will represent EMMA in Central and Eastern Europe, covering markets including Austria, Poland, Czech Republic, Hungary, Slovenia, Slovakia, Croatia, Romania, Bulgaria, Bosnia & Herzegovina, Serbia, and North Macedonia — leveraging Biomedica’s extensive regional presence and multi-country footprint.

A Partner with Deep Scientific & Microbiology Expertise

With over 40 years of experience as a multinational distributor of medical devices, in-vitro diagnostics, and life sciences solutions, Biomedica serves hospitals, research institutes, pharmaceutical, biotech, and industrial laboratories across more than 10 countries through a robust network of local offices and partners.

Biomedica’s comprehensive portfolio includes high-quality research reagents, instruments, consumables, and support services across multiple disciplines — including bacteriology, quality control, culture tools and environmental monitoring products — with dedicated expertise in industrial and pharmaceutical microbiology where EMMA’s automated reading technology aligns with customer needs for compliance and efficiency.

Driving Modern Microbiology Workflows

As regulatory focus on data integrity, contamination control strategies, and audit-ready processes continues to grow across European GMP environments, EMMA offers laboratories:

• AI-assisted plate triage & CFU analysis
• Fully compliant workflows (21 CFR Part 11, EU Annex 11)
• Digital audit trails and reduced manual effort

Biomedica will provide local sales, installation support, service, training, and maintenance, ensuring customers can adopt EMMA smoothly alongside existing quality control systems.

“We are excited to work with Biomedica, whose scientific expertise and broad portfolio make them a trusted partner for modern microbiology and QC workflows,” said Wouter Christiaens, CEO at Microtechnix. “Their strong multi-market reach will accelerate EMMA’s impact across Central and Eastern Europe.”

About Microtechnix

Microtechnix develops EMMA, an automated plate reading solution designed for regulated quality control environments in pharmaceutical, biotech, and industrial microbiology laboratories. EMMA enhances data integrity, compliance, and operational efficiency.

About Biomedica Medizinprodukte GmbH

Biomedica, founded in Vienna over 40 years ago, is a major distributor of medical devices, in-vitro diagnostics, life sciences products, and analytical services. Serving hospitals, research institutions, and industrial laboratories across Europe and beyond, Biomedica offers extensive product portfolios, scientific expertise, local support, and tailored solutions — including in bacteriology, culture media, environmental monitoring, and industrial microbiology.